Sumitomo Mitsui DS Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Sumitomo Mitsui DS Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-28,683	Closed	-$1.55M	–	797
2017 Q4	$1.55M	Buy	+28,683	New	+$1.57M	0.02%	417

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Sumitomo Mitsui DS Asset Management's BIVV Position: Q1 2018 in Review

Sumitomo Mitsui DS Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 28,683 shares — an estimated $1.55M sold.

Sumitomo Mitsui DS Asset Management first reported a position in BIVV in Q4 2017 and held it in 1 quarter. The position peaked at $1.55M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Sumitomo Mitsui DS Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Sumitomo Mitsui DS Asset Management sold 28,683 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $1.55M.
Sumitomo Mitsui DS Asset Management first reported a position in Bioverativ Inc. Common Stock in Q4 2017 and held it in 1 quarter.
Sumitomo Mitsui DS Asset Management's Bioverativ Inc. Common Stock position peaked at $1.55M in Q4 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q1 2018, filed 25 Apr 2018.